Lauris has a strong science background with a degree in Immunology and Biochemistry; and a PhD and 6 years post-doctoral experience covering cell expression systems, protein purification, mass spectrometry, protein crystallography and bioinformatics. Her patent work reflects this broad base.
Lauris is particularly adept with difficult patent cases, both European and US, getting important grants with commercially useful claims for clients. This includes European opposition cases where her attention to detail and tenacity are core to her success.
Having worked with many US in-house counsels including those in the food industry, DNA sequencing technology and antibody therapies to draft applications and manage large European and global portfolios, Lauris knows how to best assist in-house counsel. She adapts her way of working to whatever fits best with the way the in-house team likes to work, effectively becoming another member of the team.
She uses this proactive approach in assisting all her clients and is known for being on the telephone often to establish a rapport with the client to understand their science and how to guide them commercially.
Immunology and Biochemistry
By Managing IP
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.